Two Sigma Investments
AGIO icon

Two Sigma Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Two Sigma Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,000
Closed -$200K – 3049
2017
Q3 		$200K Buy
+3,000
New +$180K ﹤0.01% 2592

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Two Sigma Investments's AGIO Position: Q2 2026 in Review

Two Sigma Investments increased its Agios Pharmaceuticals (AGIO) stake by 113% in Q2 2026, buying an estimated $8.64M and bringing the position to 536,380 shares worth $19.9M. The position accounts for 0.01% of the portfolio, ranked #1059.

Two Sigma Investments first reported a position in AGIO in Q2 2015 and has held it in 17 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Two Sigma Investments held 536,380 shares of Agios Pharmaceuticals worth $19.9M as of Q2 2026.
  • Two Sigma Investments bought 284,744 Agios Pharmaceuticals shares in Q2 2026, an estimated $8.64M.
  • Agios Pharmaceuticals made up 0.01% of Two Sigma Investments's portfolio in Q2 2026, its #1059 holding.
  • Two Sigma Investments first reported a position in Agios Pharmaceuticals in Q2 2015 and has held it in 17 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.